Beam Therapeutics to Present New Preclinical Data on Base Editing Programs for Hemoglobinopathies at ASH 2019
Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced that it will present preclinical data for the company's programs addressing sickle cell disease and beta thalassemia, two blood disorders that lack effective, disease-modifying treatments, at the 61st Annual American Society of Hematology (ASH) Annual Meeting, being held December 7-10, 2019 in Orlando, Fla.
Details of the new data being presented in a poster at ASH are as follows:
Title: Complementary base editing approaches for the treatment of sickle cell disease and Beta-thalassemia
Date & Time: Sunday, December 8, 2019, 6:00-8:00 p.m. ET
Poster Session: 801 ? Gene Therapy and Transfer: Poster II
Location: Orange County Convention Center, Hall B
Presenter: Ling Lin, Ph.D., senior scientist II, Beam Therapeutics
About Beam Therapeutics
Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Beam is headquartered in Cambridge, Massachusetts. For additional information, visit www.BeamTx.com.
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting.
Details for the public webcast are as follows:
TIME:...
Riskified Ltd. , a leader in ecommerce fraud and risk intelligence, today announced it will release its first quarter 2024 financial results before the market opens on May 15, 2024. On that day management will host a conference call and webcast at...
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....
ACTS LAW's Doug Rochen currently represents more than 1,000 men and women who have been subjected to sexual abuse, sexual assault and sexual harassment while incarcerated in jails and prisons throughout California.
Recently, the Federal Correctional...
Nuvei Corporation ("Nuvei" or the "Company") , the Canadian fintech company, today announced it will publish its first quarter 2024 results after market close on May 7, 2024....
Collaboration on TSMC's COUPE silicon photonics platform dramatically speeds chip-to-chip and machine-to-machine communication for cloud, datacenters, HPC, and AI chips
/ Key Highlights
Ansys and TSMC deliver a high-fidelity multiphysics solution to...
